FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/02/2026
Voltar para busca
Dado oficial do USPTO
A
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 3, 5, 40, 42
Data de depósito
13/04/2023
Data de registro
03/06/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/06/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
27
Localização do titular
DE
Examinador
UKAOMA, ULOMA JANET
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a stylized letter "A" comprised of a circle, an elongated semi-circle, a semi-circle, and a curved triangle.
Titulares e representantes
Titulares
Axplora Group GmbH
Representantes
B. Michelle Alvey Husch Blackwell LLP
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Unprocessed chemical productsunprocessed plasticsunprocessed polymersunprocessed artificial resins; biochemical catalystscatalysts for chemical and biochemical processescatalysts for use in the manufacture of industrial chemicals; chemical reagents for non-medical purposes; chemical additives for use in the manufacture of pharmaceuticalsagrochemicalscosmeticsfood productspolymers; chemical products as chemical synthesis intermediates for industrial purposes; active chemical ingredients for use in manufacture of pharmaceuticalsagrochemicalscosmeticsfood productspolymers; hemi synthesis productssemi-synthesized chemical products for use in biotechnological product development; fertilizers; chemical products as intermediates for the production of pharmaceuticalveterinarymedical and cosmetic active ingredients
Classe 3
Purified essential oil extractsfor industrial use in the pharmaceuticalcosmeticsagrochemistryfoodpolymers industries
Classe 5
Pharmaceuticalveterinarysanitary productssteroidsdiuretic preparationsanti-inflammatory preparationsdietary supplementsnutritional supplementsdiagnostic agents for medical purposes being visualization agents for use during colonoscopiescontraceptive preparationspreparations for the treatment of burnspharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agentpharmaceutical preparations and substances for the treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonaryoncologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalimmune system related diseases and disorders; fungicidesherbicidesinsecticidespesticides
Classe 40
Contract manufacturing of pharmaceutical and chemicals and their components for third parties; contract manufacturing of pharmaceuticalschemicals and biopharmaceuticals; custom manufacturing of vaccine adjuvantsvaccinesproteinssemi-synthetic moleculesconjugated moleculesnucleic acidspolysaccharidesother therapeutic biomolecules; custom manufacturing on a pilot and commercial scale of vaccine adjuvantsvaccinesproteinssemi-synthetic moleculesconjugated moleculesnucleic acidspolysaccharides and other therapeutic biomolecules; custom manufacturing in the nature of processing of functional food and food ingredients; custom manufacturing in the nature of processing on pilot and commercial scale of functional food and food ingredients; custom manufacturing of chemical productsactive pharmaceutical ingredients and synthetic intermediatesagrochemical active ingredients and synthetic intermediates; custom manufacturing on a pilot and commercial scale of chemical productsactive pharmaceutical ingredients and synthetic intermediatesagrochemical active ingredients and synthetic intermediates; custom manufacturing of chemicals through chemical syntheses; processing of biochemicals through the synthesis of biological products for customers in the foodchemicalagriculturalveterinary and pharmaceutical industries; custom synthesis of intermediate products in the nature of intermediate organic products for industrial purposes for the foodchemicalagriculturalveterinarypharmaceutical industries; contract manufacturing of hazardous products being glycerol trinitrateazidesexplosives and other industrial chemicals for third parties; contract custom manufacturing of substitution aromates and chiral molecules for use in synthesis of products for others for third parties; preparation of galenic formulations for otherscustom manufacture of pharmaceuticals by pharmaceutical compounders
Classe 42
Providing quality controlanalytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing productsnotably for the foodchemicalagriculturalveterinarypharmaceutical industries; scientific research in the field of galenic formsspecifically for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/01/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
05/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/04/2025
PUBO
PUBLISHED FOR OPPOSITION
15/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/12/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/08/2024
GNRT
NON-FINAL ACTION E-MAILED
07/08/2024
CNRT
NON-FINAL ACTION WRITTEN
07/08/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2024
RFNP
REFUSAL PROCESSED BY IB
25/10/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/10/2023
RFRR
REFUSAL PROCESSED BY MPU
02/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/09/2023
CNRT
NON-FINAL ACTION WRITTEN
13/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/09/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace A ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.